Partner

Korea Drug Development Fund (KDDF) Joins as Co-organizer at The 8th ACCESS ASIA BD Forum @ JPM 2027

January 10, 2027 (InterContinental San Francisco) — We are delighted to announce that the Korea Drug Development Fund (KDDF) has joined The 8th ACCESS ASIA BD Forum @ JPM 2027 as a Co-organizer, further strengthening the event’s mission to bridge Asia’s most innovative biotech ecosystems with global pharma, investors, and cross-border collaborators.

KDDF’s participation brings not only Korea’s largest government-backed drug development expertise to the forum, but also expands our network through Korea Innovation Angels, a coalition of Korea’s leading early-stage biotech investors, accelerators, and industry innovators committed to supporting global partnering and innovation-driven growth.

Together, KDDF and Korea Innovation Angels will enhance ACCESS ASIA’s platform by fostering deeper collaboration between Korean innovators and global stakeholders seeking high-quality science, emerging assets, and strategic co-development opportunities.

About Korea Drug Development Fund (KDDF)

The Korea Drug Development Fund (KDDF) is a national R&D initiative jointly supported by three Korean government ministries, with a total budget of approximately USD 1.5 billion (KRW 2.2 trillion) for the period 2021–2030.

KDDF is dedicated to advancing innovative drug development in Korea by providing non-dilutive R&D funding, commercialization support, and global partnering opportunities.

By helping Korean biotech and pharmaceutical innovators overcome critical development and commercialization challenges, KDDF aims to bridge the gap between scientific innovation and global markets, accelerating the translation of promising discoveries into innovative medicines for patients worldwide.

About The 8th ACCESS ASIA BD Forum @ JPM 2027

The 8th ACCESS ASIA BD Forum @ JPM 2027 is scheduled to be held on January 10, 2027, at the InterContinental San Francisco.

This full-day forum will feature keynote speeches, panel discussions, corporate presentations, company showcases, and 1-on-1 partnering meetings connecting Asia’s leading biotech innovators with global pharma, investors, and strategic partners and global companies a platform to out-license and showcase their assets to China and Asian market.

Conference Name: The 8th ACCESS ASIA BD Forum @ JPM 2027
Date & Venue: January 10, 2027 | InterContinental San Francisco
View more information at: https://biotochina.org/2026/10/28/access-asia-jpm2027/

Agenda: https://biotochina.org/agenda/

Please keep checking back for more exciting speakers and session additions

MORE INFORMATION

Contact Us

To register as an attendee for The 8th ACCESS ASIA BD Forum @ JPM 2027, please visit:

https://jsj.top/f/AqkB9m?x_field_1=KDDF

For more information, please contact:

Wendi Xiang

Wxiang@yafocapital.com